Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
US Revenue	3.31B	3.31B	3.12B
Other Established Markets Revenue	1.92B	1.86B	1.71B
Total Established Markets Revenue	5.23B	5.16B	4.83B
Emerging Markets Revenue	1.08B	1.00B	980.00M
Revenue (Other)	-1.00M	-	-
Revenue (Total)	6.30B	6.16B	5.81B

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Knee Implants Revenue	1.00B	1.01B	977.00M
Hip Implants Revenue	655.00M	641.00M	619.00M
Other Reconstruction Revenue	139.00M	136.00M	101.00M
Trauma & Extremities Revenue	661.00M	649.00M	608.00M
Total Orthopaedics Revenue	2.46B	2.44B	2.31B
Sports Medicine Joint Repair Revenue	1.13B	1.07B	982.00M
Arthroscopic Enabling Technologies Revenue	681.00M	647.00M	632.00M
ENT (Ear, Nose and Throat) Revenue	216.00M	220.00M	210.00M
Total Sports Medicine & ENT Revenue	2.03B	1.93B	1.82B
Advanced Wound Care Revenue	798.00M	766.00M	735.00M
Advanced Wound Bioactives Revenue	600.00M	621.00M	581.00M
Advanced Wound Devices Revenue	418.00M	406.00M	365.00M
Total Advanced Wound Management Revenue	1.82B	1.79B	1.68B
Revenue (Other)	-1.00M	-	-
Revenue (Total)	6.30B	6.16B	5.81B

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Orthopaedics Segment Profit	-	363.00M	265.00M
Sports Medicine & ENT Segment Profit	-	461.00M	437.00M
Advanced Wound Management Segment Profit	-	447.00M	399.00M
Operating Income (Total)	813.00M	794.00M	657.00M